Bigfinite is a provider of data analytics and AI solutions for optimizing the pharmaceutical manufacturing process.
Bigfinite's solutions transforms manufacturing operations with the use of advanced analytics, artificial intelligence, and pharma 4.0 technologies focused on optimizing pharmaceutical and biotech companies.
Bigfinite was founded in 2014 by Pep Gubau, Pere Merino, & Toni Manzano. The company is based in San Francisco, California and also has a European office in Barcelona, Spain.
Bigfinite's goal is to be the global partner in providing simple solutions to the analysis and control complex needs of industrial processes in Biotech and Pharma, covering all the supply chain, from R+D to patient dispensing.
The Bigfinite analytics platform seamlessly integrates unlimited sources of structured and unstructured data to deliver actionable insights across all manufacturing sites. The company's AI-powered solution that helps pharmaceutical and biotech companies discover new ways to optimize manufacturing processes, reduce quality issues, and enhance regulatory compliance.
Bigfinite offers an intuitive way to gain meaningful operational intelligence with data by enabling real-time visibility and predictive insights in a GxP compliant manner with end-to-end data integrity.
Bigfinite is backed by Atlantic Bridge, Crosslink Capital, Uncork Capital (formerly SoftTech VC), Honeywell Ventures, Institut Català de Finances and others. The company raised $15M from a "Series B" financing on Nov 4, 2019. This new round brings Bigfinite's total funding to $23.6M to date.